Bloodstream infections in internal medicine

Virulence

Volumn 7, Issue 3, 2016, Pages 353-365

  Del Bono, Valerio ^a   Giacobbe, Daniele Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

bloodstream infections; BSI; internal medicine; medical wards; sepsis

Indexed keywords

AVIBACTAM PLUS CEFTAZIDIME; C REACTIVE PROTEIN; CEFTAROLINE; CEFTOBIPROLE; CEFTOLOZANE PLUS TAZOBACTAM; COLISTIN; DAPTOMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; ORITAVANCIN; PROCALCITONIN; TEDIZOLID; TEICOPLANIN; TELAVANCIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BLOODSTREAM INFECTION; CANDIDA; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; COMORBIDITY; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; INTERNAL MEDICINE; MORBIDITY; MORTALITY; POLYPHARMACY; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ADVERSE EFFECTS; AGE; AGED; BACTEREMIA; COMMUNICABLE DISEASES; CROSS INFECTION; DISEASE MANAGEMENT; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; RISK FACTOR;

AGE FACTORS; AGED; ANTI-INFECTIVE AGENTS; BACTEREMIA; CANDIDA; COMMUNICABLE DISEASES; CROSS INFECTION; DISEASE MANAGEMENT; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSION; INTERNAL MEDICINE; MALE; RISK FACTORS; STAPHYLOCOCCUS AUREUS;

EID: 84964478798     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2016.1140296     Document Type: Review

References (134)

1. United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2012 Revision, Press Release (13 June 2013). http://esa.un.org/unpd/wpp/Documentation/pdf/WPP2012_Press_Release.pdf 2013
2. H.J.Heppner, S.Cornel, W.Peter, B.Philipp, S.Katrin. Infections in the elderly. Crit Care Clin 2013; 29:757-74; PMID:23830661; http://dx.doi.org/10.1016/j.ccc.2013.03.016
3. M.Juthani-Mehta, V.J.Quagliarello. Infectious diseases in the nursing home setting: challenges and opportunities for clinical investigation. Clin Infect Dis 2010; 51:931-6; PMID:20822459; http://dx.doi.org/10.1086/656411
4. C.L.Beckett, S.Harbarth, B.Huttner. Special considerations of antibiotic prescription in the geriatric population. Clin Microbiol Infect 2015; 21:3-9; PMID:25636920; http://dx.doi.org/10.1016/j.cmi.2014.08.018
5. M.Bassetti, M.P.Molinari, M.Mussap, C.Viscoli, E.Righi. Candidaemia in internal medicine departments: the burden of a rising problem. Clin Microbiol Infect 2013; 19:E281-4; PMID:23414070; http://dx.doi.org/10.1111/1469-0691.12155
6. A.J.Odden, J.M.Rohde, C.Bonham, L.Kuhn, P.N.Malani, L.M.Chen, S.A.Flanders, T.J.Iwashyna. Functional outcomes of general medical patients with severe sepsis. BMC Infect Dis. England 2013; 13:588
7. J.M.Rohde, A.J.Odden, C.Bonham, L.Kuhn, P.N.Malani, L.M.Chen, S.A.Flanders, T.J.Iwashyna. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 2013; 8:243-7; PMID:23401431; http://dx.doi.org/10.1002/jhm.2012
8. C.Pope, S.Ziebland, N.Mays. Qualitative research in health care. Analyzing qualitative data. BMJ 2000; 320:114-6; PMID:10625273; http://dx.doi.org/10.1136/bmj.320.7227.114
9. R.C.Bone, R.A.Balk, F.B.Cerra, R.P.Dellinger, A.M.Fein, W.A.Knaus, R.M.Schein, W.J.Sibbald. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55; http://dx.doi.org/10.1378/chest.101.6.1644
10. D.C.Angus, W.T.Linde-Zwirble, J.Lidicker, G.Clermont, J.Carcillo, M.R.Pinsky. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-10; PMID:11445675; http://dx.doi.org/10.1097/00003246-200107000-00002
11. S.Karlsson, E.Ruokonen, T.Varpula, T.I.Ala-Kokko, V.Pettila. Long-term outcome and quality-adjusted life years after severe sepsis. Crit Care Med 2009; 37:1268-74; PMID:19242321; http://dx.doi.org/10.1097/CCM.0b013e31819c13ac
12. B.D.Winters, M.Eberlein, J.Leung, D.M.Needham, P.J.Pronovost, J.E.Sevransky. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010; 38:1276-83; PMID:20308885
13. A.Esteban, F.Frutos-Vivar, N.D.Ferguson, O.Penuelas, J.A.Lorente, F.Gordo, T.Honrubia, A.Algora, A.Bustos, G.García, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007; 35:1284-9; PMID:17414725; http://dx.doi.org/10.1097/01.CCM.0000260960.94300.DE
14. H.Wisplinghoff, T.Bischoff, S.M.Tallent, H.Seifert, R.P.Wenzel, M.B.Edmond. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:1093; http://dx.doi.org/10.1086/421946
15. M.A.Pfaller, R.N.Jones, G.V.Doern, K.Kugler. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42:1762-70; PMID:9661018
16. M.Rodríguez-Créixems, L.Alcalá, P.Muñoz, E.Cercenado, T.Vicente, E.Bouza. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) 2008; 87:234-49; http://dx.doi.org/10.1097/MD.0b013e318182119b
17. H.S.Sader, R.N.Jones, S.Andrade-Baiocchi, D.J.Biedenbach. SENTRY Participants Group (Latin America). Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 2002; 44:273-80; PMID:12493175; http://dx.doi.org/10.1016/S0732-8893(02)00469-8
18. C.C.Lai, Y.H.Chen, S.H.Lin, K.P.Chung, W.H.Sheng, W.C.Ko, P.R.Hsueh. Changing aetiology of healthcare-associated bloodstream infections at three medical centres in Taiwan, 2000-2011. Epidemiol Infect 2014; 142:2180-5; PMID:25116133; http://dx.doi.org/10.1017/S0950268813003166
19. S.J.Albrecht, N.O.Fishman, J.Kitchen, I.Nachamkin, W.B.Bilker, C.Hoegg, C.Samel, S.Barbagallo, J.Arentzen, E.Lautenbach. Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med 2006; 166:1289-94; PMID:16801511; http://dx.doi.org/10.1001/archinte.166.12.1289
20. P.Nordmann, L.Dortet, L.Poirel. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 2012; 18:263-72; PMID:22480775; http://dx.doi.org/10.1016/j.molmed.2012.03.003
21. M.Tumbarello, E.M.Trecarichi, F.G.De Rosa, M.Giannella, D.R.Giacobbe, M.Bassetti, A.R.Losito, M.Bartoletti, V.Del Bono, S.Corcione, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015; 70:2133-43; PMID:25900159; http://dx.doi.org/10.1093/jac/dkv200
22. J.D.Pitout, K.B.Laupland. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8:159-66; PMID:18291338
23. R.Cantón, A.Novais, A.Valverde, E.Machado, L.Peixe, F.Baquero, T.M.Coque. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14 S1:144-53; PMID:Can't; http://dx.doi.org/10.1111/j.1469-0691.2007.01850.x
24. K.Bush. Extended-spectrum β-lactamases in North America, 1987-2006. Clin Microbiol Infect 2008; 14 S1:134-43; PMID:18154537; http://dx.doi.org/10.1111/j.1469-0691.2007.01848.x
25. R.Cantón, T.M.Coque. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9:466-75; http://dx.doi.org/10.1016/j.mib.2006.08.011
26. P.M.Hawkey. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 2008; 14 S1:159-65; PMID:18154540; http://dx.doi.org/10.1111/j.1469-0691.2007.01855.x
27. T.Giani, B.Pini, F.Arena, V.Conte, S.Bracco, R.Migliavacca, A.Pantosti, L.Pagani, F.Luzzaro, G.M.Rossolini. AMCLI-CRE Survey Participants. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 2013; 18:pii 20489; PMID:23787077
28. L.S.Munoz-Price, L.Poirel, R.A.Bonomo, M.J.Schwaber, G.L.Daikos, M.Cormican, G.Cornaglia, J.Garau, M.Gniadkowski, M.K.Hayden, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96; PMID:23969216; http://dx.doi.org/10.1016/S1473-3099(13)70190-7
29. A.Endimiani, A.M.Hujer, F.Perez, C.R.Bethel, K.M.Hujer, J.Kroeger, M.Oethinger, D.L.Paterson, M.D.Adams, M.R.Jacobs, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA. J Antimicrob Chemother 2009; 63:427-37; PMID:19155227; http://dx.doi.org/10.1093/jac/dkn547
30. L.Ma, J.T.Wang, T.L.Wu, L.K.Siu, Y.C.Chuang, J.C.Lin, M.C.Lu, P.L.Lu. Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan. PLoS ONE 2015; 10: e0139152; PMID:26414183; http://dx.doi.org/10.1371/journal.pone.0139152
31. S.Corcione, A.Rocchetti, P.A.Argentero, R.Raso, C.M.Zotti, F.G.De Rosa, V.Ghisetti. A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU. Clin Microbiol Infect 2015; 21:e11-3; PMID:25682279; http://dx.doi.org/10.1016/j.cmi.2014.09.012
32. D.R.Giacobbe, V.Del Bono, A.Marchese, C.Viscoli. Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? Clin Microbiol Infect 2014; 20(12):O1157-8
33. C.Alicino, D.R.Giacobbe, A.Orsi, F.Tassinari, C.Trucchi, G.Sarteschi, F.Copello, V.Del Bono, C.Viscoli, G.Icardi. Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BMC Infect Dis 2015; 15:415; PMID:26464061; http://dx.doi.org/10.1186/s12879-015-1152-0
34. M.Bassetti, M.Merelli, E.Righi, A.Diaz-Martin, E.M.Rosello, R.Luzzati, A.Parra, E.M.Trecarichi, M.Sanguinetti, B.Posteraro, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 2013; 51(12):4167-72; PMID:24108614; http://dx.doi.org/10.1128/JCM.01998-13
35. D.L.Horn, D.Neofytos, E.J.Anaissie, J.A.Fishman, W.J.Steinbach, A.J.Olyaei, K.A.Marr, M.A.Pfaller, C.H.Chang, K.M.Webster. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48:1695-703; PMID:19441981; http://dx.doi.org/10.1086/599039
36. O.Marchetti, J.Bille, U.Fluckiger, P.Eggimann, C.Ruef, J.Garbino, T.Calandra, M.P.Glauser, M.G.Täuber, D.Pittet. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004; 38:311-20; PMID:14727199; http://dx.doi.org/10.1086/380637
37. H.Wisplinghoff, J.Ebbers, L.Geurtz, D.Stefanik, Y.Major, M.B.Edmond, R.P.Wenzel, H.Seifert. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 2014; 43:78-81; PMID:24182454; http://dx.doi.org/10.1016/j.ijantimicag.2013.09.005
38. L.R.Asmundsdottir, H.Erlendsdottir, M.Gottfredsson. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 2002; 40:3489-92; PMID:12202600; http://dx.doi.org/10.1128/JCM.40.9.3489-3492.2002
39. R.Luzzati, S.Cavinato, M.L.Deiana, C.Rosin, C.Maurel, M.Borelli. Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards. Aging Clin Exp Res 2014; 27(2):131-7; PMID:24923673
40. M.Nucci, F.Queiroz-Telles, T.Alvarado-Matute, I.N.Tiraboschi, J.Cortes, J.Zurita, M.Guzman-Blanco, M.E.Santolaya, L.Thompson, J.Sifuentes-Osornio, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One 2013; 8:e59373; PMID:23527176; http://dx.doi.org/10.1371/journal.pone.0059373
41. M.A.Pfaller, S.A.Messer, G.J.Moet, R.N.Jones, M.Castanheira. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011; 38:65-9; PMID:21514797; http://dx.doi.org/10.1016/j.ijantimicag.2011.02.016
42. M.Falcone, E.Concia, I.Iori, G.Lo Cascio, A.Mazzone, F.Pea, F.Violi, M.Venditti. Identification and management of invasive mycoses in internal medicine: a road-map for physicians. Intern Emerg Med 2014; 9:501-11; PMID:24871636; http://dx.doi.org/10.1007/s11739-014-1077-4
43. K.P.High. Infection in an ageing world. Lancet Infect Dis 2002; 2:655; PMID:12409042; http://dx.doi.org/10.1016/S1473-3099(02)00434-6
44. I.Raad, H.Hanna, M.Boktour, E.Girgawy, H.Danawi, M.Mardani, D.Kontoyiannis, R.Darouiche, R.Hachem, G.P.Bodey. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 2004; 38:1119-27; PMID:15095217; http://dx.doi.org/10.1086/382874
45. D.J.Rychly, J.T.DiPiro. Infections associated with tumor necrosis factor-α antagonists. Pharmacotherapy 2005; 25:1181-92; PMID:16164393; http://dx.doi.org/10.1592/phco.2005.25.9.1181
46. B.Coburn, A.M.Morris, G.Tomlinson, A.S.Detsky. Does this adult patient with suspected bacteremia require blood cultures? JAMA 2012 Aug 1; 308:502-11; http://dx.doi.org/10.1001/jama.2012.8262
47. O.Stojadinovic, H.Brem, C.Vouthounis, B.Lee, J.Fallon, M.Stallcup, A.Merchant, R.D.Galiano, M.Tomic-Canic. Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005; 167:59-69; PMID:15972952; http://dx.doi.org/10.1016/S0002-9440(10)62953-7
48. T.C.van der Pouw Kraan, W.J.Chen, M.C.Bunck, D.H.van Raalte, N.J.van der Zijl, R.E.van Genugten, L.van Bloemendaal, J.M.Baggen, E.H.Serné, M.Diamant, et al. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity. BMC Med Genomics 2015; 8:20; PMID:25956355; http://dx.doi.org/10.1186/s12920-015-0096-y
49. S.L.Wong, M.Demers, K.Martinod, M.Gallant, Y.Wang, A.B.Goldfine, C.R.Kahn, D.D.Wagner. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med 2015; 21(7):815-9
50. F.W.LoGerfo, J.D.Coffman. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984; 311:1615-9; PMID:6390204; http://dx.doi.org/10.1056/NEJM198412203112506
51. S.Noor, M.Zubair, J.Ahmad. Diabetic foot ulcer-A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 2015; 9(3):192-9; PMID:25982677
52. J.E.Tooke, P.D.Brash. Microvascular aspects of diabetic foot disease. Diabet Med 1996; 13 Suppl 1:S26-9; PMID:8741825
53. T.Bruns, H.W.Zimmermann, A.Stallmach. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20:2542-54; PMID:24627590; http://dx.doi.org/10.3748/wjg.v20.i10.2542
54. E.K.Steffen, R.D.Berg, E.A.Deitch. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 1988; 157:1032-8; PMID:3283254; http://dx.doi.org/10.1093/infdis/157.5.1032
55. B.A.Runyon, S.Squier, M.Borzio. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21:792-6; PMID:7890896; http://dx.doi.org/10.1016/S0168-8278(94)80241-6
56. E.Scarpellini, V.Valenza, M.Gabrielli, E.C.Lauritano, G.Perotti, G.Merra, A.Dal Lago, V.Ojetti, M.E.Ainora, M.Santoro, et al. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 2010; 105:323-7; PMID:19844200; http://dx.doi.org/10.1038/ajg.2009.558
57. Z.Teltschik, R.Wiest, J.Beisner, S.Nuding, C.Hofmann, J.Schoelmerich, C.L.Bevins, E.F.Stange, J.Wehkamp. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 2012; 55:1154-63; PMID:22095436; http://dx.doi.org/10.1002/hep.24789
58. G.S.Alarcon. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Infect Dis Clin North Am 2006; 20:849-75; PMID:17118293; http://dx.doi.org/10.1016/j.idc.2006.09.007
59. M.Marin, C.Gudiol, C.Garcia-Vidal, C.Ardanuy, J.Carratala. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore) 2014; 93:143-9; PMID:24797169; http://dx.doi.org/10.1097/MD.0000000000000026
60. S.Schelenz, D.Nwaka, P.R.Hunter. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother 2013; 68:1431e8; http://dx.doi.org/10.1093/jac/dkt002
61. M.Marin, C.Gudiol, C.Ardanuy, C.Garcia-Vidal, M.Calvo, M.Arnan, J.Carratalà. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. J Infect 2014; 69:417-23; PMID:24960295; http://dx.doi.org/10.1016/j.jinf.2014.05.018
62. J.E.Goasguen, J.M.Bennett, B.J.Bain, R.Brunning, M.T.Vallespi, M.Tomonaga, G.Zini, A.Renault S. Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 2014; 38:447-53; PMID:24439566; http://dx.doi.org/10.1016/j.leukres.2013.12.020
63. D.P.Steensma, A.Tefferi. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res 2003; 27:95-120; PMID:12526916; http://dx.doi.org/10.1016/S0145-2126(02)00098-X
64. J.Marschall. Catheter-associated bloodstream infections: looking outside of the ICU. Am J Infect Control. United States 2008:S172 e5-8
65. Y.Rhee, M.Heung, B.Chen, C.E.Chenoweth. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis. Infect Control Hosp Epidemiol 2015; 36:424-30; PMID:25782897; http://dx.doi.org/10.1017/ice.2014.86
66. R.Tedja, S.M.Gordon, C.Fatica, T.G.Fraser. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings. Infect Control Hosp Epidemiol 2014; 35:164-8; PMID:24442079; http://dx.doi.org/10.1086/674856
67. R.P.Vonberg, M.Behnke, C.Geffers, D.Sohr, H.Ruden, M.Dettenkofer, S.Gastmeier. Device-associated infection rates for non-intensive care unit patients. Infect Control Hosp Epidemiol 2006; 27:357-61; PMID:16622812; http://dx.doi.org/10.1086/503339
68. P.Pronovost, D.Needham, S.Berenholtz, D.Sinopoli, H.Chu, S.Cosgrove, B.Sexton, R.Hyzy, R.Welsh, G.Roth, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-32; PMID:17192537; http://dx.doi.org/10.1056/NEJMoa061115
69. W.E.Trick, M.O.Vernon, S.F.Welbel, M.F.Wisniewski, J.A.Jernigan, R.A.Weinstein. Unnecessary use of central venous catheters: the need to look outside the intensive care unit. Infect Control Hosp Epidemiol 2004; 25:266-8; PMID:15061422; http://dx.doi.org/10.1086/502390
70. V.Chopra, J.C.O'Horo, M.A.Rogers, D.G.Maki, N.Safdar. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2013; 34:908-18; PMID:23917904; http://dx.doi.org/10.1086/671737
71. E.Durante-Mangoni, S.Bradley, C.Selton-Suty, M.F.Tripodi, B.Barsic, E.Bouza, C.H.Cabell, A.I.Ramos, V.Fowler, Jr, B.Hoen, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008; 168:2095-103; PMID:18955638; http://dx.doi.org/10.1001/archinte.168.19.2095
72. L.Wang, B.Lansing, K.Symons, E.L.Flannery, J.Fisch, K.Cherian, S.E.McNamara, L.Mody. Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices. Eur J Clin Microbiol Infect Dis 2012; 31:1797-804; PMID:22274858; http://dx.doi.org/10.1007/s10096-011-1504-7
73. V.Cornejo-Dávila, M.A.Palmeros-Rodríguez, I.Uberetagoyena-Tello de Meneses, E.Mayorga-Gómez, G.Garza-Sáinz, V.Osornio-Sánchez, et al. Management of complicated urinary tract infections in a referral center in Mexico. Int Urol Nephrol 2015; 47:229-33; http://dx.doi.org/10.1007/s11255-014-0883-y
74. C.C.Lee, S.Y.Chen, I.J.Chang, S.C.Chen, S.C.Wu. Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine (Baltimore) 2007; 86:138-44; PMID:17505253; http://dx.doi.org/10.1097/SHK.0b013e318067da56
75. F.M.Wagenlehner, C.Lichtenstern, C.Rolfes, K.Mayer, F.Uhle, W.Weidner, M.A.Weigand. Diagnosis and management for urosepsis. Int J Urol 2013; 20:963-70; PMID:23714209
76. M.Bassetti, L.Taramasso, E.Nicco, M.P.Molinari, M.Mussap, C.Viscoli. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6:e24198; PMID:21935385; http://dx.doi.org/10.1371/journal.pone.0024198
77. S.Rajagopalan. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 2005; 40:990-6; PMID:15824991; http://dx.doi.org/10.1086/427690
78. R.Luzzati, S.Cavinato, M.Giangreco, G.Grana, S.Centonze, M.L.Deiana, G.Biolo, F.Barbone. Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case-control study. Mycoses 2013; 56:664-71; PMID:23675641; http://dx.doi.org/10.1111/myc.12090
79. M.L.Branchini, M.A.Pfaller, J.Rhine-Chalberg, T.Frempong, H.D.Isenberg. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32:452-6; PMID:8150956
80. K.Swindell, A.A.Lattif, J.Chandra, P.K.Mukherjee, M.A.Ghannoum. Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces. J Infect Dis 2009; 200:473-80; PMID:19552524; http://dx.doi.org/10.1086/600106
81. G.Samonis, E.Galanakis, M.Ntaoukakis, E.Sarchianaki, T.Spathopoulou, D.Dimopoulou, D.P.Kofteridis, S.Maraki. Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans. Mycoses 2013; 56:105-9; PMID:22680984; http://dx.doi.org/10.1111/j.1439-0507.2012.02212.x
82. G.Samonis, A.Gikas, E.J.Anaissie, G.Vrenzos, S.Maraki, Y.Tselentis, G.P.Bodey. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993; 37:51-3; PMID:8431017; http://dx.doi.org/10.1128/AAC.37.1.51
83. P.Chassagne, M.B.Perol, J.Doucet, C.Trivalle, J.F.Menard, N.D.Manchon, Y.Moynot, G.Humbert, J.Bourreille, E.Bercoff. Is presentation of bacteremia in the elderly the same as in younger patients? Am J Med 1996; 100:65-70; PMID:8579089; http://dx.doi.org/10.1016/S0002-9343(96)90013-3
84. S.J.Jeong, S.S.Yoon, S.H.Han, D.E.Yong, C.O.Kim, J.M.Kim. Evaluation of humoral immune response to nosocomial pathogen and functional status in elderly patients with sepsis. Arch Gerontol Geriatr 2014; 58:10-4; PMID:23998496; http://dx.doi.org/10.1016/j.archger.2013.07.001
85. G.Gavazzi, K.H.Krause. Ageing and infection. Lancet Infect Dis 2002; 2:659-66; PMID:12409046; http://dx.doi.org/10.1016/S1473-3099(02)00437-1
86. C.M.Blatteis. Age-dependent changes in temperature regulation - a mini review. Gerontology 2012; 58:289-95; PMID:22085834; http://dx.doi.org/10.1159/000333148
87. P.Gabriel, I.Cakman, L.Rink. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 2002; 37:235-47; PMID:11772509; http://dx.doi.org/10.1016/S0531-5565(01)00189-9
88. B.Grubeck-Loebenstein, P.Berger, M.Saurwein-Teissl, K.Zisterer, G.Wick. No immunity for the elderly. Nat Med 1998; 4:870; PMID:9701220; http://dx.doi.org/10.1038/nm0898-870b
89. J.Born, D.Uthgenannt, C.Dodt, D.Nunninghoff, E.Ringvolt, T.Wagner, H.L.Fehm. Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech Ageing Dev 1995; 84:113-26; PMID:8788239; http://dx.doi.org/10.1016/0047-6374(95)01638-4
90. K.S.Krabbe, M.Pedersen, H.Bruunsgaard. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39:687-99; PMID:15130663; http://dx.doi.org/10.1016/j.exger.2004.01.009
91. D.C.Angus, T.van der Poll. Severe sepsis and septic shock. N Engl J Med 2013; 369:840-51; PMID:23984731; http://dx.doi.org/10.1056/NEJMra1208623
92. S.M.Opal, T.D.Girard, E.W.Ely. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005; 41Suppl 7:S504-12; PMID:16237654; http://dx.doi.org/10.1086/432007
93. M.D.Richardson. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56Suppl 1:i5-i11; PMID:16120635; http://dx.doi.org/10.1093/jac/dki218
94. H.C.Chen, W.L.Lin, C.C.Lin, W.H.Hsieh, C.H.Hsieh, M.H.Wu, J.Y.Wu, C.C.Lee. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother 2013; 68:947-53; PMID:23264512; http://dx.doi.org/10.1093/jac/dks475
95. P.Retamar, M.M.Portillo, M.D.Lopez-Prieto, F.Rodriguez-Lopez, M.de Cueto, M.V.Garcia, M.J.Gómez, A.Del Arco, A.Muñoz, A.Sánchez-Porto, et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 2012; 56:472-8; PMID:22005999; http://dx.doi.org/10.1128/AAC.00462-11
96. M.Tumbarello, P.Viale, C.Viscoli, E.M.Trecarichi, F.Tumietto, A.Marchese, T.Spanu, S.Ambretti, F.Ginocchio, F.Cristini, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55:943-50; PMID:22752516; http://dx.doi.org/10.1093/cid/cis588
97. K.L.Becker, R.Snider, E.S.Nylen. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36:941-52; PMID:18431284; http://dx.doi.org/10.1097/CCM.0B013E318165BABB
98. A.A.Dahaba, P.H.Rehak, W.F.List. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003; 29:579-83; PMID:12652350
99. J.A.Foushee, N.H.Hope, E.E.Grace. Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays. J Antimicrob Chemother 2012; 67:2560-9; PMID:22833636; http://dx.doi.org/10.1093/jac/dks265
100. O.Burkhardt, S.Ewig, U.Haagen, S.Giersdorf, O.Hartmann, K.Wegscheider, E.Hummers-Pradier, T.Welte. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010; 36:601-7; PMID:20185423; http://dx.doi.org/10.1183/09031936.00163309
101. P.E.Charles, F.Dalle, S.Aho, J.P.Quenot, J.M.Doise, H.Aube, N.O.Olsson, B.Blettery. Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 2006; 32:1577-83; PMID:16896850; http://dx.doi.org/10.1007/s00134-006-0306-3
102. S.H.Hoeboer, P.J.van der Geest, D.Nieboer, A.B.Groeneveld. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect 2015; 21:474-81; PMID:25726038; http://dx.doi.org/10.1016/j.cmi.2014.12.026
103. A.Martini, L.Gottin, N.Menestrina, V.Schweiger, D.Simion, J.L.Vincent. Procalcitonin levels in surgical patients at risk of candidemia. J Infect 2010; 60:425-30; PMID:20226210; http://dx.doi.org/10.1016/j.jinf.2010.03.003
104. C.J.Clancy, M.H.Nguyen. Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56:1284-92; PMID:23315320; http://dx.doi.org/10.1093/cid/cit006
105. V.Del Bono, E.Delfino, E.Furfaro, M.Mikulska, E.Nicco, P.Bruzzi, A.Mularoni, M.Bassetti, C.Viscoli. Clinical Performance of the (1,3)-β-D-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections. Clin Vaccine Immunol 2011; 18:2113-7; PMID:21994353; http://dx.doi.org/10.1128/CVI.05408-11
106. B.Posteraro, G.De Pascale, M.Tumbarello, R.Torelli, M.A.Pennisi, G.Bello, R.Maviglia, G.Fadda, M.Sanguinetti, M.Antonelli. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1–>3)-β-D-glucan assay, Candida score, and colonization index. Crit Care 2011; 15:R249; PMID:22018278; http://dx.doi.org/10.1186/cc10507
107. M.Cuenca-Estrella, P.E.Verweij, M.C.Arendrup, S.Arikan-Akdagli, J.Bille, J.P.Donnelly, H.E.Jensen, C.Lass-Flörl, M.D.Richardson, M.Akova, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18 Suppl 7:9-18; PMID:23137134
108. M.C.Arendrup, O.J.Bergmann, L.Larsson, H.V.Nielsen, J.O.Jarløv, B.Christensson. Detection of candidaemia in patients with and without underlying haematological disease. Clin Microbiol Infect 2010; 16:855-62; http://dx.doi.org/10.1111/j.1469-0691.2009.02931.x
109. M.Prella, J.Bille, M.Pugnale, B.Duvoisin, M.Cavassini, T.Calandra, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51:95-101; PMID: 15698714; http://dx.doi.org/10.1016/j.diagmicrobio.2004.08.015
110. M.Mikulska, T.Calandra, M.Sanguinetti, D.Poulain, C.Viscoli; Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010; 14:R222; PMID:21143834; http://dx.doi.org/10.1186/cc9365
111. P.G.Pappas, C.A.Kauffman, D.R.Andes, C.J.Clancy, K.A.Marr, L.Ostrosky-Zeichner, A.C.Reboli, M.G.Schuster, J.A.Vazquez, T.J.Walsh, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62(4):e1-e50.
112. D.R.Andes, N.Safdar, J.W.Baddley, G.Playford, A.C.Reboli, J.H.Rex, J.D.Sobel, P.G.Pappas, B.J.Kullberg. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012; 54:1110-22; PMID:22412055; http://dx.doi.org/10.1093/cid/cis021
113. J.Garnacho-Montero, T.Aldabo-Pallas, M.Palomar-Martinez, J.Valles, B.Almirante, R.Garces, F.Grill, M.Pujol, C.Arenas-Giménez, E.Mesalles, et al. Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med 2008; 34:2185-93; PMID:18622596; http://dx.doi.org/10.1007/s00134-008-1204-7
114. M.Bassetti, E.M.Trecarichi, A.Mesini, T.Spanu, D.R.Giacobbe, M.Rossi, E.Shenone, G.D.Pascale, M.P.Molinari, R.Cauda, et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2012; 18:862-9; PMID:21999245; http://dx.doi.org/10.1111/j.1469-0691.2011.03679.x
115. G.L.Daikos, S.Tsaousi, L.S.Tzouvelekis, I.Anyfantis, M.Psichogiou, A.Argyropoulou, I.Stefanou, V.Sypsa, V.Miriagou, M.Nepka, et al. Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems. Antimicrob Agents Chemother 2014; 58:2322-8; PMID:24514083; http://dx.doi.org/10.1128/AAC.02166-13
116. M.Tumbarello, G.De Pascale, E.M.Trecarichi, T.Spanu, F.Antonicelli, R.Maviglia, M.A.Pennisi, G.Bello, M.Antonelli. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 2013; 39:682-92; PMID:23370828; http://dx.doi.org/10.1007/s00134-013-2828-9
117. M.Papadimitriou-Olivgeris, M.Christofidou, F.Fligou, C.Bartzavali, T.Vrettos, K.S.Filos, M.Marangos, E.D.Anastassiou. The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients. Infection 2014; 42:883-90; PMID:25008195; http://dx.doi.org/10.1007/s15010-014-0653-x
118. M.Tumbarello, E.M.Trecarichi, F.Tumietto, V.Del Bono, F.G.De Rosa, M.Bassetti, A.R.Losito, S.Tedeschi, C.Saffioti, S.Corcione, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2014; 58:3514-20; PMID:24733460; http://dx.doi.org/10.1128/AAC.02373-13
119. D.R.Giacobbe, V.Del Bono, E.M.Trecarichi, F.G.De Rosa, M.Giannella, M.Bassetti, A.Bartoloni, A.R.Losito, S.Corcione, M.Bartoletti, et al. Risk factors for bloostream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. Clin Microbiol Infect 2015; 21:1106.e1-8; PMID:26278669
120. F.Kontopidou, H.Giamarellou, P.Katerelos, A.Maragos, I.Kioumis, E.Trikka-Graphakos, C.Valakis, H.C.Maltezou. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect 2013; 20(2):O117-23
121. Z.A.Qureshi, D.L.Paterson, B.A.Potoski, M.C.Kilayko, G.Sandovsky, E.Sordillo, B.Polsky, J.M.Adams-Haduch, Y.Doi. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56:2108-13; PMID:22252816; http://dx.doi.org/10.1128/AAC.06268-11
122. M.Paul, Y.Carmeli, E.Durante-Mangoni, J.W.Mouton, E.Tacconelli, U.Theuretzbacher, C.Mussini, L.Leibovici. Combination therapy for carbapenem-resistant Gram-negative bacteria. J Antimicrob Chemother 2014; 69:2305-9; PMID:24872346; http://dx.doi.org/10.1093/jac/dku168
123. F.G.De Rosa, S.Corcione, N.Pagani, G.Di Perri. From ESKAPE to ESCAPE, from KPC to CCC. Clin Infect Dis 2015; 60(8):1289-90; PMID:25537879; http://dx.doi.org/10.1093/cid/ciu1170
124. M.Papadimitriou-Olivgeris, A.Spiliopoulou, F.Fligou, P.Manolopoulou, I.Spiliopoulou, T.Vrettos, V.Dodou, K.S.Filos, E.D.Anastassiou, M.Marangos, et al. Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species. Diagn Microbiol Infect Dis 2014; 80:227-32; PMID:25175179; http://dx.doi.org/10.1016/j.diagmicrobio.2014.07.012
125. V.Schechner, T.Kotlovsky, M.Kazma, H.Mishali, D.Schwartz, S.Navon-Venezia, M.J.Schwaber, Y.Carmeli. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013; 19:451-6; PMID:22563800; http://dx.doi.org/10.1111/j.1469-0691.2012.03888.x
126. M.J.Schwaber, S.Klarfeld-Lidji, S.Navon-Venezia, D.Schwartz, A.Leavitt, Y.Carmeli. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028-33; PMID:18086836; http://dx.doi.org/10.1128/AAC.01020-07
127. O.A.Cornely, M.Bassetti, T.Calandra, J.Garbino, B.J.Kullberg, O.Lortholary, W.Meersseman, M.Akova, M.C.Arendrup, S.Arikan-Akdagli, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18 Suppl 7:19-37; PMID:23137135; http://dx.doi.org/10.1111/1469-0691.12039
128. K.B.Laupland, A.W.Kirkpatrick, A.Delaney. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 2007; 35:2686-2692; PMID:18074465; http://dx.doi.org/10.1097/01.CCM.0000295312.13466.1C
129. J.L.Vincent. Emerging therapies for the treatment of sepsis. Curr Opin Anaesthesiol 2015; 28:411-6; PMID:26087275; http://dx.doi.org/10.1097/ACO.0000000000000210
130. S.Deresinski. Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data. Clin Infect Dis 2007; 45 Suppl 3:S177-83; PMID:17712744; http://dx.doi.org/10.1086/519472
131. D.R.Giacobbe, P.Esteves, P.Bruzzi, M.Mikulska, E.Furfaro, A.Mesini, P.Tatarelli, S.Grignolo, C.Viscoli, A.L.Colombo, et al. Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil. Clin Microbiol Infect 2015; 21:954.e9-954.e17; PMID:26070961
132. S.Jaijakul, J.A.Vazquez, R.N.Swanson, L.Ostrosky-Zeichner. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis 2012; 55:521-6; PMID:22573851; http://dx.doi.org/10.1093/cid/cis456
133. K.W.Hamilton, N.O.Fishman. Antimicrobial stewardship interventions: thinking inside and outside the box. Infect Dis Clin North Am 2014; 28:301-13; PMID:24857395; http://dx.doi.org/10.1016/j.idc.2014.01.003
134. E.Charani, J.Cooke, A.Holmes. Antibiotic stewardship programmes–what's missing? J Antimicrob Chemother 2010; 65:2275-7; PMID:20851812; http://dx.doi.org/10.1093/jac/dkq357